Lipid and protein changes in sciatic nerve during Wallerian degeneration.
D000818:Animals; D002554:Cerebrosides / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D002855:Chromatography, Thin Layer; D004589:Electrophoresis, Disc; D004952:Esters; D006023:Glycoproteins / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D050356:Lipid Metabolism; D008970:Molecular Weight; D009186:Myelin Sheath / Q000378:metabolism; D009410:Nerve Degeneration; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D010713:Phosphatidylcholines / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D012584:Sciatic Nerve / Q000166:cytology / Q000378:metabolism*; D013109:Sphingomyelins / Q000378:metabolism; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism
D002554:Cerebrosides; D004952:Esters; D006023:Glycoproteins; D007202:Indicators and Reagents; D009419:Nerve Tissue Proteins; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D013109:Sphingomyelins; D014280:Triglycerides; D002784:Cholesterol